Importantly, the overexpression of ABC transporters at the BBB or the blood–brain tumor barrier (BBTB), as well as in the tumor cells, is often observed [15], which can lead to an improved multidrug resistance [16]. This evidence concerns the gene ABCG2 and brain neoplasm.